BioCentury
ARTICLE | Clinical News

Excelimmune preclinical data

September 27, 2010 7:00 AM UTC

In mice, Excelimmune's human recombinant polyclonal antibody (HRPA) against MRSA produced 100% survival against doses of S. aureus that were 100% lethal in untreated control mice. The HRPA therapy con...